Location History:
- Malnate, Varese, IT (1977 - 1978)
- Malnate, IT (1980 - 1983)
Company Filing History:
2 out of 5 
1 out of 1 
1 out of 12 Years Active: 1977-1983
Title: Luigi Molteni: Innovator in Pharmaceutical Chemistry
Introduction
Luigi Molteni is a notable inventor based in Malnate, Italy, recognized for his contributions to pharmaceutical chemistry. With a total of five patents to his name, Molteni has made significant advancements in the field, particularly in the development of new compounds and their applications in medical treatments.
Latest Patents
One of Molteni's latest patents describes a process for preparing 1-(3,5-dimethoxy-4-hydroxyphenyl)-2-(N-methylamino) ethanol hydrochloride. This innovative process involves reacting 2,6-dimethoxyphenol with anhydrous chloral in the presence of a catalyst, followed by hydrolyzing 1-(3,5-dimethoxy-4-hydroxyphenyl) 2,2,2-trichloro ethanol. The final product is obtained through amination with methylamine and subsequent conversion into hydrochloride. Another significant patent involves the use of rifamycin SV and its related salts in the treatment of rheumatoid arthritis. This invention highlights new salts of rifamycin SV and their application through intra-articular injection, showcasing the potential for improved therapeutic outcomes.
Career Highlights
Throughout his career, Molteni has worked with esteemed companies such as Dr. L. Zambeletti Spa and Dr. L. Zambeletti S.p.a. His work in these organizations has allowed him to refine his expertise and contribute to various innovative projects in the pharmaceutical sector.
Collaborations
Molteni has collaborated with notable professionals in his field, including Innocenzo Caruso and Franco Montrone. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in pharmaceutical research.
Conclusion
Luigi Molteni's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an innovator in the field. His work continues to influence the development of new treatments and compounds, showcasing the importance of innovation in healthcare.